Randomized, double blind, placebo-controlled, in parallel clinical study to compare pharmacokinetics profile of Phase I clinical trial testing drug to originator with a single dose of Gerilimzumab injection in healthy adult volunteers
Phase of Trial: Phase I
Latest Information Update: 03 Nov 2017
At a glance
- Drugs Gerilimzumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Genor Biopharma
- 01 Nov 2017 Status changed to recruiting.
- 11 Jan 2017 New trial record
- 24 Dec 2016 According to a Genor Biopharma media release, the company has received clinical trial approval from the China Food and Drug Administration (CFDA) for gerilimzumab.